Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome

Summary

We plan to examine the gastrointestinal (GI) physiologic profile of Exenatide, a glucagon-like peptide (GLP-1) analog as a possible intestino-trophic growth factor capable of inducing small bowel adaptation and regeneration in patients with short bowel syndrome (SBS), with the potential to decrease parenteral nutrition dependence.

Timeline

Start

2013-03

Primary completion

2014-01

Completion

2014-01

Drugs

Indications